KYNB- Fibrogen Inc
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 8 buys and 4 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $402.0K | - | |
| CFO | 26.0K | $174.2K | - | |
| Dir | 7.0K | $46.9K | - | |
| Dir | 7.0K | $46.9K | - | |
| Dir | 7.0K | $46.9K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Wettig Thane70 | CEO | Buy | 3,700 | $9.12 | $33,749.73 | +8.5% | -15.7% | - | |
| Jun 30, 2025 | Schoeneck James A47 | Director | Buy | 23,567 | $5.07 | $119,484.69 | +146.4% | +132.4% | - | |
| Mar 24, 2025 | Wettig Thane70 | CEO | Buy | 145,000 | $0.35 | $50,663.00 | +36.4% | -41.5% | -26.8% | |
| Mar 21, 2025 | Schoeneck James A47 | Director | Buy | 300,000 | $0.35 | $105,040.00 | +75.5% | -27.0% | -9.5% | |
| Jun 12, 2024 | Adib Deyaa | Chief Medical Officer | Buy | 22,123 | $1.17 | $25,883.91 | +36.9% | -65.5% | -73.4% | |
| Mar 7, 2024 | Wettig Thane70 | CEO | Buy | 50,000 | $1.91 | $95,470.00 | +11.9% | -32.4% | -79.3% | |
| Sep 1, 2023 | Henderson Jeffrey William65 | Director | Sell | 2,000 | $1.03 | $2,060.00 | -6.5% | -47.9% | -65.5% | |
| Aug 4, 2023 | Henderson Jeffrey William65 | Director | Sell | 2,000 | $1.91 | $3,820.00 | -6.1% | -70.3% | -77.6% | |
| Jul 11, 2023 | Henderson Jeffrey William65 | Director | Sell | 2,000 | $2.69 | $5,380.00 | -5.7% | -73.6% | -66.9% | |
| Jul 7, 2023 | Conterno Enrique A87 | Chief Executive Officer | Sell | 1,880 | $2.80 | $5,264.00 | -0.5% | -73.4% | -73.3% |
Page 1Next →